BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6330360)

  • 1. Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones.
    Heeres J; Backx LJ; Van Cutsem J
    J Med Chem; 1984 Jul; 27(7):894-900. PubMed ID: 6330360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimycotic azoles. 6. Synthesis and antifungal properties of terconazole, a novel triazole ketal.
    Heeres J; Hendrickx R; Van Cutsem J
    J Med Chem; 1983 Apr; 26(4):611-3. PubMed ID: 6834396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Henna: the cosmetic antimycotic drug].
    Itani ZS
    Hautarzt; 1973 Feb; 24(2):83-5. PubMed ID: 4570883
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-Candida activity of azoles].
    Van Cutsem J; Van Gerven F; Janssen PA
    Ann Biol Clin (Paris); 1987; 45(6):661-8. PubMed ID: 2830810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models.
    Van Cutsem J; Van Gerven F; Janssen PA
    Rev Infect Dis; 1987; 9 Suppl 1():S15-32. PubMed ID: 3027843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo activities of the novel azole antifungal agent r126638.
    Odds F; Ausma J; Van Gerven F; Woestenborghs F; Meerpoel L; Heeres J; Vanden Bossche H; Borgers M
    Antimicrob Agents Chemother; 2004 Feb; 48(2):388-91. PubMed ID: 14742185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The therapeutic effects of itraconazole, a new triazole antifungal agent, for experimental fungal infections].
    Uchida K; Yamaguchi H; Shibuya K
    Jpn J Antibiot; 1991 May; 44(5):588-99. PubMed ID: 1652657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antimycotic effect of Astrantia-, Eryngium- and Sanicula saponins].
    Hiller K; Friedrich E
    Pharmazie; 1974 Dec; 29(12):787-8. PubMed ID: 4617889
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental findings on a new, orally active broad-spectrum antimycotic agent].
    Plempel M; Bartmann K; Büchel KH; Regel E
    Dtsch Med Wochenschr; 1969 Jun; 94(26):1356-8 passim. PubMed ID: 5815123
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral itraconazole versus topical bifonazole treatment in experimental dermatophytosis.
    Borgers M; Xhonneux B; Van Cutsem J
    Mycoses; 1993; 36(3-4):105-15. PubMed ID: 8396203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optically active antifungal azoles. VIII. Synthesis and antifungal activity of 1-[(1R,2R)-2-(2,4-difluoro- and 2-fluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]- 3-(4-substituted phenyl)-2(1H,3H)-imidazolones and 2-imidazolidinones.
    Kitazaki T; Tasaka A; Tamura N; Matsushita Y; Hosono H; Hayashi R; Okonogi K; Itoh K
    Chem Pharm Bull (Tokyo); 1999 Mar; 47(3):351-9. PubMed ID: 10212385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Van Cutsem J
    Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fungal morphology after treatment with itraconazole as a single oral dose in experimental vaginal candidosis in rats.
    Jansen TM; Van de Ven MA; Borgers MJ; Odds FC; Van Cutsem JM
    Am J Obstet Gynecol; 1991 Nov; 165(5 Pt 1):1552-7. PubMed ID: 1659787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of terbinafine in experimental fungal infections of laboratory animals.
    Petranyi G; Meingassner JG; Mieth H
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1558-61. PubMed ID: 3435103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationships of naftifine-related allylamine antimycotics.
    Stütz A; Georgopoulos A; Granitzer W; Petranyi G; Berney D
    J Med Chem; 1986 Jan; 29(1):112-25. PubMed ID: 3510297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical antimycotic activity of SDZ 89-485: a new orally and topically effective triazole.
    Schaude M; Petranyi G; Ackerbauer H; Meingassner JG; Mieth H
    J Med Vet Mycol; 1990; 28(6):445-54. PubMed ID: 2093117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antifungal activity of novel thiazole-containing triazole antifungals.
    Tsuruoka A; Kaku Y; Kakinuma H; Tsukada I; Yanagisawa M; Naito T
    Chem Pharm Bull (Tokyo); 1997 Jul; 45(7):1169-76. PubMed ID: 9246751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Griseofulvin analogs derived from transformations of 5'-formylgriseofulvin.
    Fields TL; Newman H; Angier RB
    J Med Chem; 1971 Aug; 14(8):767-9. PubMed ID: 5114073
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis of novel water soluble benzylazolium prodrugs of lipophilic azole antifungals.
    Ohwada J; Murasaki C; Yamazaki T; Ichihara S; Umeda I; Shimma N
    Bioorg Med Chem Lett; 2002 Oct; 12(19):2775-80. PubMed ID: 12217374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degenerative changes in fungi after itraconazole treatment.
    Borgers M; Van de Ven MA
    Rev Infect Dis; 1987; 9 Suppl 1():S33-42. PubMed ID: 3027844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.